It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objective: Rotavirus enteritis (RV-e) continues to play a major role in hospitalization and morbidity in patients with acute gastroenteritis (AGE). Identifying new biomarkers that can improve risk assessment of RV-e is crucial for effective disease management. This study aimed to evaluate systemic immune/inflammatory index (SII) markers and hemoglobin, albumin, lymphocyte, and platelet score (HALP score) in children with RV-e.
Materials and Methods: This retrospective cohort study was conducted in the pediatric emergency outpatient clinic (PEOC) of a tertiary-level training and research hospital, involving 816 patients. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and HALP score were used to evaluate inflammation in cases of rotavirus (RV) and other types of enteritis.
Results: A total of 816 patients were included in the study, of whom 45.3% were female and 54.7% were male. The hospitalization rate due to RV-e was higher than that of non-RV-e cases, with 47.5% (n=85) of RV-e patients being hospitalized (p<0.001). Both NLR and PLR were elevated in hospitalized patients within the RV-e group (p<0.001 for both). Hospitalization was found to be 1.45 times more likely (95% confidence interval [CI]: 1.09-1.94) among patients with low HALP scores, six times more likely (95% CI: 3.52-10.26) in patients with RV-e, and 2.88 times more likely (95% CI: 1.40-5.88) in children under five years of age.
Conclusion: This study demonstrated that the frequency of hospitalization increased in patients with low HALP scores. We think that the HALP score may serve as a simple and rapid marker to aid clinicians in early treatment planning, especially for patients diagnosed with RV-e in emergency settings.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





